China Anti-tumor Drugs Market Report 2007 - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/554481

China Anti-tumor Drugs Market Report 2007

Description:

The anti-tumor drugs market operated well in 2006, and the total sales volume amounted to USD 34.6 billion, up 20.5% from a year earlier, and the growth margin ranked the first place among all the treatment categories to be the most important drive force for promoting the global drugs market. According to the increase trend in recent five years, it is forecasted that the anti-tumor drugs will probably be the unit product with the largest sales income in the global drugs market.

According to the forecast of IXIS, the molecule-targeted drugs will stand out singly, its annual compound growth rate (ACGR) will reach 23% in 2005-2010, and the market share will be from 39% in 2005 to 53.6% in 2010.

The total sales of anti-tumor drugs (except traditional Chinese medicine) in China amounted to RMB 6.002 billion in 2006, up 23.94% year-on-year. It is forecasted that the total sales of anti-tumor drugs (except traditional Chinese medicine) in China will reach RMB 7.6 billion in 2007, rising above 25% from a year earlier.

Contents:

1 Status Quo and Development Trend of Global Anti-tumor Drugs Market
1.1 Classified Anti-tumor drugs become the rapidest increase field in global drugs market
1.2 Molecule-targeted drugs of anti-tumor increases fast
1.3 R&D of anti-tumor drugs field is still active

2 Chinese Anti-tumor Drugs Market
2.1 Chinese anti-tumor drugs Market
2.2 Chinese enterprises

3 Major Companies
3.1 Hengrui
3.2 Hansoh
3.3 Hisun
3.4 Wanle

Drugs Industry Development Trend
R/E Ratio Change of Roche, 2001-2007
Tumor Patient Occurrence Rate in China
Sales Change of Anti-tumor drugs (except Traditional Chinese Medicine) in China
Forecast of Hengrui Sales Income
Main Anti-tumor Drugs Increase of Hengrui
Docetaxel Sales Income and Increase of Hengrui
Oxaliplatin Sales Income and Increase of Hengrui
Irinotecan Hydrochloride Infusion Sales Income and Increase of Hengrui
Sales Income of Hansoh
Main Anti-tumor Drugs of Hansoh
Sales Income of Hisun
Main Anti-tumor Drugs of Hisun
Sales Income of Wanle
Current Equity Structure of Wanle
Top Ten Classified Drugs in Global Drugs Market by Sales, 2006
Forecast of Top Three Anti-tumor Drugs Increase
Forecast of Anti-tumor Drugs Market Shares of Key Companies
Top Global 500 Anti-tumor Drugs by Sales, 2005
Main Classifications of Anti-tumor Drugs in China
Chinese Enterprises with Sales Income of Anti-tumor Drugs above RMB 100 Million
Foreign Enterprises with Sales Income of Anti-tumor Drugs above RMB 100 Million
Market Shares Change Trend of China Anti-tumor Drugs (excluding Traditional Chinese Medicine)

Companies Mentioned

Hengrui, Hansoh, Hism and Wanle

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/554481

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 11/10/2008 06:55:42

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
China Anti-tumor Drugs Market Report 2007
Web Address:
http://www.researchandmarkets.com/reports/554481
Office Code:
OCHKELLLMPX

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Hard Copy		€221.00 + EUR€ 50.00 Shipping/Handling *
	Electronic (PDF)		€221.00
	Electronic - Enterprisewide		€442.00

* Shipping/Handling is only charged once per order.

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 11/10/2008 06:55:42

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World